2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$11.60+$0.38 (+3.39%)
Price as of Nov 11, 2026 7:30 PM EST- $326.8MMarket Cap
- -6.81%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$11.60+$0.38 (+3.39%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.22 | ||
Change | -$0.25 (-2.18%) | ||
Open | $11.40 | ||
High | $11.64 | ||
Low | $10.98 | ||
Previous Close | $11.47 | ||
Volume | 353,601 | ||
30-Day Average Volume | 255,421 | ||
1-Week Change | 8.20% | ||
1-Month Change | -10.24% | ||
1-Year Change | -6.81% | ||
3-Year Change | 35.84% | ||
5-Year Change | -87.49% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $296.9M | ||
Market Cap | $326.8M | ||
Enterprise Value | $293.4M | ||
Period: QTR TTM FY | |||
Revenue | $14.4M | ||
Net Income | -$19.5M | ||
Free Cash Flow | -$10.0M | ||
EBIT | -$15.3M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $149.5M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 3 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||